Quince Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TUDOR INVESTMENT CORP ET AL | 08/14/2026 | 117.80 K | $2.14 M | 100.00% | 0.10% |
| TUDOR INVESTMENT CORP ET AL | 08/14/2026 | 115.80 K | $2.11 M | 100.00% | 0.09% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 72.25 K | $1.31 M | 100.00% | 0.06% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 70.78 K | $1.29 M | 100.00% | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 69.97 K | $12.56 M | 100.00% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 55.00 K | $1.00 M | 100.00% | 0.04% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 40.38 K | $734.42 K | 100.00% | 0.03% |
| SHAY CAPITAL LLC | 08/14/2026 | 17.47 K | $329.27 K | 100.00% | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 13.91 K | $253.04 K | 100.00% | 0.01% |
| JANE STREET GROUP, LLC | 08/14/2026 | 12.64 K | $229.96 K | 100.00% | 0.01% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 12.04 K | $219.08 K | 100.00% | 0.01% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2026 | 5.50 K | $100.01 K | 100.00% | 0.00% |
| UBS GROUP AG | 08/13/2026 | 4.73 K | $86.04 K | 100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 4.08 K | $74.29 K | 100.00% | 0.00% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 3.61 K | $65.74 K | 100.00% | 0.00% |
| BLACKROCK, INC. | 08/07/2026 | 1.70 K | $30.96 K | 100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 567 | $10.31 K | 100.00% | 0.00% |
| GEN-WEALTH PARTNERS INC | 08/10/2026 | 165 | $3.00 K | 100.00% | 0.00% |
| OPEROSE ADVISORS LLC | 08/13/2026 | 159 | $2.89 K | 100.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 07/20/2026 | 40 | $728 | 100.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 27 | $491 | 100.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 12 | $218 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 10 | $182 | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 08/11/2026 | 8 | $137 | 100.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 6 | $109 | 100.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 08/05/2026 | 3 | $55 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 2 | $2 | 100.00% | 0.00% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 07/27/2026 | 1 | $18 | 100.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 1 | $18 | 100.00% | 0.00% |
| JDM FINANCIAL GROUP LLC | 08/18/2026 | 1 | $18 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MARINER, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 07/30/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 09/02/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SCHARF INVESTMENTS, LLC | 07/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
Quince Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 69 institutional investors and hedge funds held shares of Quince Therapeutics Inc. The most heavily invested institutionals were:
Ikarian Capital, LLC: 72,251
MILLENNIUM MANAGEMENT LLC: 70,779
BALYASNY ASSET MANAGEMENT L.P.: 69,967
Squadron Capital Management LLC: 40,375
Shay Capital LLC: 17,468
BOOTHBAY FUND MANAGEMENT, LLC: 13,911
0.27% of Quince Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.75 M shares in the last 24 months. This purchase volume represents approximately $412.04 K in transactions.